However, after stratification according to tumor size, we found that in the small-sized group (≤ 2 cm), the LNs involvement rate of patients with TP53 missense mutation remained as high as 54.8% compared with TP53WT cases (vs. 23.5%, P = 0.010). The gene discussed is TP53; the disease is neoplasm.